» Articles » PMID: 22301832

Genetic Variation in Peroxisome Proliferator-activated Receptor Gamma, Soy, and Mammographic Density in Singapore Chinese Women

Overview
Date 2012 Feb 4
PMID 22301832
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: PPARγ is a transcription factor important for adipogenesis and adipocyte differentiation. Data from animal studies suggest that PPARγ may be involved in breast tumorigenesis, but results from epidemiologic studies on the association between PPARγ variation and breast cancer risk have been mixed. Recent data suggest that soy isoflavones can activate PPARγ. We investigated the interrelations of soy, PPARγ, and mammographic density, a biomarker of breast cancer risk in a cross-sectional study of 2,038 women who were members of the population-based Singapore Chinese Health Study Cohort.

Methods: We assessed mammographic density using a computer-assisted method. We used linear regression to examine the association between 26 tagging single-nucleotide polymorphisms (SNP) of PPARγ and their interaction with soy intake and mammographic density. To correct for multiple testing, we calculated P values adjusted for multiple correlated tests (P(ACT)).

Results: Out of the 26 tested SNPs in the PPARγ, seven SNPs were individually shown to be statistically significantly associated with mammographic density (P(ACT) = 0.008-0.049). A stepwise regression procedure identified that only rs880663 was independently associated with mammographic density which decreased by 1.89% per-minor allele (P(ACT) = 0.008). This association was significantly stronger in high-soy consumers as mammographic density decreased by 3.97% per-minor allele of rs880663 in high-soy consumers (P(ACT) = 0.006; P for interaction with lower soy intake = 0.017).

Conclusions: Our data support that PPARγ genetic variation may be important in determining mammographic density, particularly in high-soy consumers.

Impact: Our findings may help to identify molecular targets and lifestyle intervention for future prevention research.

Citing Articles

Understanding mammographic breast density profile in China: A Sino-Australian comparative study of breast density using real-world data from cancer screening programs.

Li T, Li J, Heard R, Gandomkar Z, Ren J, Dai M Asia Pac J Clin Oncol. 2022; 18(6):696-705.

PMID: 35238173 PMC: 9790382. DOI: 10.1111/ajco.13763.


Breast cancer risk factors and mammographic density among high-risk women in urban China.

Sung H, Ren J, Li J, Pfeiffer R, Wang Y, Guida J NPJ Breast Cancer. 2018; 4:3.

PMID: 29423438 PMC: 5802809. DOI: 10.1038/s41523-018-0055-9.


A Randomized Controlled Trial of Green Tea Extract Supplementation and Mammographic Density in Postmenopausal Women at Increased Risk of Breast Cancer.

Samavat H, Ursin G, Emory T, Lee E, Wang R, Torkelson C Cancer Prev Res (Phila). 2017; 10(12):710-718.

PMID: 28904061 PMC: 7337967. DOI: 10.1158/1940-6207.CAPR-17-0187.


Biological underpinnings of breastfeeding challenges: the role of genetics, diet, and environment on lactation physiology.

Lee S, Kelleher S Am J Physiol Endocrinol Metab. 2016; 311(2):E405-22.

PMID: 27354238 PMC: 5005964. DOI: 10.1152/ajpendo.00495.2015.


Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55.

Ozhand A, Lee E, Wu A, Ellingjord-Dale M, Akslen L, McKean-Cowdin R PLoS One. 2013; 8(6):e65313.

PMID: 23762340 PMC: 3676419. DOI: 10.1371/journal.pone.0065313.


References
1.
Wang Y, McCullough M, Stevens V, Rodriguez C, Jacobs E, Teras L . Nested case-control study of energy regulation candidate gene single nucleotide polymorphisms and breast cancer. Anticancer Res. 2007; 27(1B):589-93. View

2.
Larsson S, Mantzoros C, Wolk A . Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007; 121(4):856-62. DOI: 10.1002/ijc.22717. View

3.
Maskarinec G, Meng L . An investigation of soy intake and mammographic characteristics in Hawaii. Breast Cancer Res. 2001; 3(2):134-41. PMC: 13924. DOI: 10.1186/bcr285. View

4.
Ursin G, Astrahan M, Salane M, Parisky Y, PEARCE J, Daniels J . The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev. 1998; 7(1):43-7. View

5.
Greendale G, Reboussin B, Slone S, Wasilauskas C, Pike M, Ursin G . Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst. 2003; 95(1):30-7. DOI: 10.1093/jnci/95.1.30. View